GVHD severity, donor-recipient blood type impact thromboembolic event risk
In patients who develop chronic graft-versus-host disease (cGVHD) after haematopoietic cell transplantation (HCT), the risk of thromboembolic events (TEE) seems to be affected by disease severity and donor-recipient ABO blood group, a recent study has found.
Antibody cocktail cuts hospitalization, death in COVID-19
The REGN-COV2 monoclonal antibody cocktail comprising casirivimab and imdevimab significantly reduces the risk of hospitalization and all-cause death by 71 percent compared with placebo in nonhospitalized patients with COVID-19, according to a large phase III study presented at the ATS 2021 Meeting.

New Molecule

2 New

New Formulation

1 New

New Brand

18 New

Color 1
Color 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in